Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With Hormone Receptor-positive Intraductal Carcinoma of the Breast: A Multicenter, Retrospective, Real-world Study

NCT04666805 is registered in ClinicalTrials.gov with First Hospital of China Medical University as lead sponsor.

NCT NCT04666805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04666805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With Hormone Receptor-positive Intraductal Carcinoma of the Breast: A Multicenter, Retrospective, Real-world Study
Lead sponsor
First Hospital of China Medical University
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2020
Completion date
January 15, 2021
Enrollment
1,354 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer